Cologne University, Department of Chemistry, Greinstrasse 4, 50939, Cologne, Germany.
Angew Chem Int Ed Engl. 2019 Jul 29;58(31):10596-10600. doi: 10.1002/anie.201904308. Epub 2019 Jul 5.
The first generation and X-ray diffraction (XRD) analysis of a crystalline Breslow intermediate (BI) derived from a thiazolin-2-ylidene, that is, the aromatic heterocycle present in vitamin B , is reported. Key to success was the combined use of pentafluorobenzaldehyde and a thiazolin-2-ylidene carrying an enol-stabilizing dispersion energy donor as N-substituent. A so-called primary intermediate (PI) could be isolated in protonated form (pPI) as well and analyzed by XRD. Furthermore, the first stable BI derived from an aromatic thiazolin-2-ylidene and an aliphatic aldehyde (trifluoroacetaldehyde) was prepared and characterized by NMR spectroscopy in solution. When switching to a saturated thiazolidin-2-ylidene, reaction with pentafluorobenzaldehyde afforded a new BI in solution (NMR spectroscopy). Attempts to crystallize the latter BI resulted in the isolation of a novel thiazolidin-2-ylidene dimer that had undergone rearrangement to a hexahydro[1,4]-thiazino[3,2-b]-1,4-thiazine.
本文报道了首例结晶 Breslow 中间体(BI)的合成及其 X 射线衍射(XRD)分析。该中间体来源于噻唑啉-2-亚基,即维生素 B 中存在的芳香杂环。成功的关键在于同时使用五氟苯甲醛和一个带有烯醇稳定分散能给体的噻唑啉-2-亚基作为 N-取代基。可以分离质子化形式的所谓初级中间体(pPI),并通过 XRD 进行分析。此外,还制备并通过 NMR 光谱在溶液中对首例来源于芳香噻唑啉-2-亚基和脂肪醛(三氟乙醛)的稳定 BI 进行了表征。当切换到饱和的噻唑烷-2-亚基时,与五氟苯甲醛的反应在溶液中得到了一种新的 BI(NMR 光谱)。尝试结晶该 BI 得到了一种新型噻唑烷-2-亚基二聚体,该二聚体发生了重排,生成了六氢[1,4]-噻嗪并[3,2-b]-1,4-噻嗪。